Janux Therapeutics | Novel T Cell Immunotherapies tech stack

Janux Therapeutics | Novel T Cell Immunotherapies works mostly with GCP. Its stack also includes GCP. GCP is named in 6 of the 11 job postings Janux Therapeutics | Novel T Cell Immunotherapies published in the last 12 months (55%). Counted by Alion from the job postings of Janux Therapeutics | Novel T Cell Immunotherapies, updated Oct 28, 2026.

Source: Alion Coverage: the company's job postings of the last 12 months Oct 28, 2026
Technologies in use
9
Postings analysed
11
Open now
9
Modernity
54 /100
New in 6 months
2

What cloud and platforms does Janux Therapeutics | Novel T Cell Immunotherapies use?

GCP is named in 55% of job postings at Janux Therapeutics | Novel T Cell Immunotherapies.

GCP 6 55% required in 100% · 5 open now · since Jul 2026

What developer tools does Janux Therapeutics | Novel T Cell Immunotherapies use?

Microsoft Excel is named in 18% of job postings at Janux Therapeutics | Novel T Cell Immunotherapies, followed by GraphPad Prism (9%).

Microsoft Excel 2 18% required in 100% · 1 open now · since Aug 2026
GraphPad Prism 1 9% required in 100% · 1 open now · since Sep 2026

Which engineering practices does Janux Therapeutics | Novel T Cell Immunotherapies ask for?

GMP is named in 18% of job postings at Janux Therapeutics | Novel T Cell Immunotherapies, followed by Good Clinical Practice (18%), ELISA (9%), Flow Cytometry (9%).

GMP 2 18% required in 100% · 2 open now · since Sep 2026
Good Clinical Practice 2 18% required in 100% · 2 open now · since May 2026
ELISA 1 9% required in 100% · 1 open now · since Sep 2026
Flow Cytometry 1 9% required in 100% · 1 open now · since Oct 2026
HPLC 1 9% required in 100% · since Sep 2026
Single-Cell Sequencing 1 9% required in 100% · 1 open now · since Oct 2026

How does your stack fit Janux Therapeutics | Novel T Cell Immunotherapies?

Sign in to compare your skills with this stack and see which open roles fit you.
Sign In

How is the Janux Therapeutics | Novel T Cell Immunotherapies stack changing?

Read from the dates of the postings themselves: a technology is new when the first posting that names it appeared in the last six months, rising or falling when its share of postings moved between the last two quarters.

First appeared
GMPSep 2026
Microsoft ExcelAug 2026

How modern is the Janux Therapeutics | Novel T Cell Immunotherapies stack?

Established 54/100

Janux Therapeutics | Novel T Cell Immunotherapies scores 54 out of 100 (Established). The score averages how current each technology in the stack is and adds weight for AI adoption. AI technologies in the stack: 0; legacy ones: 0.

How common is the Janux Therapeutics | Novel T Cell Immunotherapies stack in its industry?

Share of the 163 companies in the same industries, whose stack Alion knows, that use each technology.

GCP72%

Questions about the Janux Therapeutics | Novel T Cell Immunotherapies tech stack

Does Janux Therapeutics | Novel T Cell Immunotherapies use GCP?

Yes. GCP is named in 6 of 11 job postings (55%) and required in 6 of them.

What cloud and platforms does Janux Therapeutics | Novel T Cell Immunotherapies use?

The cloud and platforms named in Janux Therapeutics | Novel T Cell Immunotherapies job postings are GCP (6) (postings in brackets).

Is the Janux Therapeutics | Novel T Cell Immunotherapies tech stack changing?

Yes. GMP, Microsoft Excel first appeared in Janux Therapeutics | Novel T Cell Immunotherapies job postings in the last six months.

How modern is the Janux Therapeutics | Novel T Cell Immunotherapies tech stack?

Janux Therapeutics | Novel T Cell Immunotherapies scores 54 out of 100 (Established). The score averages how current each technology in the stack is and adds weight for AI adoption. AI technologies in the stack: 0; legacy ones: 0.

How does Alion know the Janux Therapeutics | Novel T Cell Immunotherapies tech stack?

Alion reads every job posting Janux Therapeutics | Novel T Cell Immunotherapies publishes and tags the technologies each one names. The figures on this page count the 11 postings of the last 12 months and were updated on Oct 28, 2026.

Method and citation

Alion reads every job posting the company publishes and tags the technologies each one names. Shares count the postings of the last 12 months, open and closed; the company's own products are counted apart. How we count

Alion, "Janux Therapeutics | Novel T Cell Immunotherapies tech stack: 9 technologies from 11 job postings", as of Oct 28, 2026. https://alion.io/company/januxrx/technologies

Licence: CC BY-SA 4.0JSON